You are here

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Published in Association with Mary Ann Liebert

eISSN: 21679436 | ISSN: 21679436 Frequency: Bi-monthly
This journal is a peer-reviewed venue for promoting and sharing research rooted in hybridoma technology. It aims to advance the understanding of the biology and immunology that underscores the utility of antibodies as diagnostics and therapeutics. Paramount to this aim, the journal scope includes research on the biology of B cells, the production of antibodies in terms of antibody descriptions, antibody engineering innovations, and their use in diagnosis and therapy. Most importantly, the broadened scope includes aspects of biology and immunology at the level of the antibody repertoire, structural biology of the antibody, and modern omics techniques. Methodologically, these areas may include biophysical, biochemical, and computational approaches as well as informatics and database development spanning the computational, genomic, and database resources required for analyses. In the area of diagnosis and therapy, preclinical and clinical assessments of antibodies, and formulations that induce or activate antibodies are welcome. 

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is a peer-reviewed venue for promoting and sharing research rooted in hybridoma technology. It aims at advancing the understanding of the biology and immunology that underscores the utility of antibodies as diagnostics and therapeutics. Paramount to this aim the Journal scope includes research on the biology of B cells, the production of antibodies in terms of antibody descriptions, antibody engineering innovations and their use in diagnosis and therapy. Most importantly our broadened scope includes aspects of biology and immunology at the level of the antibody repertoire, structural biology of antibody and modern omics techniques. Methodologically these areas may include biophysical, biochemical and computational approaches as well as informatics and database development spanning the computational, genomic, and database resources required for analyses. In the area of diagnosis and therapy, preclinical and clinical assessments of antibodies, and formulations that induce or activate antibodies are welcomed. Submitted manuscripts can take the form of original research, short reviews, commentary, and position papers. All manuscripts will adhere to the Journal guidelines that now include statement of competing interest, and clarification statement of author contribution.

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy covers:

Diagnostics

Immunohistochemistry to characterize or identify antigens
Generation for use in molecular monitoring
Probes for disease progression
Marker discovery

Therapeutics

Antibody based therapies
Drug delivery systems including antibody-mediated nanoparticles
Combination Therapies
Design of Immunopharmaceuticals
Preclinical models and clinical studies
Vaccine/Immunization studies

Biology

Antibodies as tools in Immunology
Antibodies as probes of structure and cells
Antibodies as regulatory agents
Cellular and molecular responses to antibody immunization
BCR Repertoire Compartments

Genetics

BCR and Antibody genetics
Epigenetic influence on antibody response
Metabolic influence on antibody production
Repertoire diversification

Antibody-Antigen characterization and molecular basis of recognition

Characterization, epitope mapping
New sources for availability of fully characterized antibodies
Molecular and structural studies of antibody and fragments there of
Design and development of surrogate antibodies by protein engineering
Computational/ Informatics based analysis of antibody-antigen interaction

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is under the editorial leadership of Editor-in-Chief Cory Brooks, PhD, California State University Fresno, Fresno, CA, USA, and Deputy Editor-in-Chief Andrei Moroz, PhD, Sao Paulo State University, Araraquara, Brazil, and other leading invers.

Audience: Cell biologists, immunologists, molecular biologists, among others

Editor-in-Chief
Cory L. Brooks, PhD California State University Fresno, Fresno, CA, USA
Deputy Editor-in-Chief
Andrei Moroz, PhD Sao Paulo State University (UNESP), Araraquara, Brazil
Editorial Office
Editorial Board Members
Michael G Agadjanyan, PhD Institute For Molecular Medicine, Huntington Beach, CA, USA
Greg Hussack Ottawa, ON, Canada
Yukinari Kato, MD, PhD Tohoku University Graduate School of Medicine, Sendai, Japan
Srini V Kaveri, DVM, PhD Centre De Recherche Des Cordeliers, Paris, France
Thomas Kieber-Emmons, PhD University of Arkansas for Medical Sciences, Little Rock, AR, USA
Kisung Ko, PhD Chung-Ang University, Seoul, South Korea
Heinz Kohler, MD, PhD Immpheron Inc, Lexington, KY, USA
Ramachandran Murali, PhD Cedars Sinai Medical Center, Los Angeles, CA, USA
Anastas Pashov, MD, PhD Stephan Angelov Institute Of Microbiology, Sofia, Bulgaria
Manuel L Penichet, MD, PhD University of California Los Angeles, Los Angeles, CA, USA
Prakash Radhakrishnan, PhD University of Nebraska Medical Center, Omaha, NE, USA
Gajendra P.S. Raghava New Rochelle, NY, USA
Jean G Sathish, BVSC, MSC Pfizer Inc., Pearl River, NY, USA
Velizar Shivarov Medical University Pleven, 5800 Pleven, USA
Zenon Steplewski, MD, PhD Biotechnology Foundation Inc, Malvern, PA, USA
Magdalena Thurin, PhD New Rochelle, NY, USA
Priscila Pini Zenatti, MD, PhD Boldrini Children Center, Sao Paulo, Brazil
Individual Subscription - E-access

Institutional Subscription - E-access

Institutional Subscription & Backfile Lease - E-access Plus Backfile (All Online Content)

Subscription Information

 

To subscribe to this journal or to purchase single/back issues, please contact Customer Service - Journals: customerservicejournals@sagepub.in  +91 (11) 4063 9222 extn 406


To purchase bundled content, backfiles or any other electronic products, please contact: journalsales@sagepub.in


For exciting offers and deals, write to: jmarketing@sagepub.in